Rybelsus 00169-4303
Generic: Oral Semaglutide
Product NDC
00169-4303- Manufacturer
- Novo Nordisk Pharmaceutical Industries, Lp
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 20, 2019
- Listing Expires
- December 31, 2027
- Application
- NDA213051
Need to source Rybelsus? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Semaglutide | 3 mg/1 |
Drug Class
GLP-1 Receptor Agonist [EPC]GLP-1 Receptor Agonist [EPC]Glucagon-Like Peptide 1 [CS]
Packaging Options(2)
30 TABLET in 1 BOTTLE, GLASS (0169-4303-30)
30 TABLET in 1 BOTTLE, GLASS (0169-4303-99)